{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:07:40Z","timestamp":1779912460164,"version":"3.53.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The most frequent causes of ICH include arteriolosclerotic small vessel disease (aSVD-ICH) and cerebral amyloid angiopathy (CAA-ICH). The predominant underlying pathology and natural history of ICH patients with mixed deep and lobar location haemorrhages (MLH-ICH) remain insufficiently studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of consecutive patients with ICH admitted between 2018 and 2024 and selected patients without macrostructural cause of haemorrhage, with available magnetic resonance imaging. We compared clinical characteristics, imaging markers, cerebrospinal fluid (CSF) neurodegeneration markers and ICH recurrence in patients with CAA-ICH, MLH-ICH and aSVD-ICH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 217 patients (CAA-ICH\u00a0=\u00a087, MLH-ICH\u00a0=\u00a079, aSVD-ICH\u00a0=\u00a051), median age was 72\u00a0years (IQR\u00a0=\u00a060\u201379), and 85 patients were female (39.2%). Patients with MLH-ICH were younger than CAA-ICH patients (P\u00a0=\u00a0.009) but older than aSVD-ICH patients (P\u00a0=\u00a0.012). Absence of cortical superficial siderosis, absence of severe burden of enlarged perivascular spaces (EPVS) in the centrum semiovale, presence of severe burden of EPVS in the basal ganglia, presence of deep and lobar cerebellar microbleeds and presence of deep lacunes were independently associated with MLH-ICH. Patients with MLH-ICH had higher CSF amyloid \u03b242 (median 719 vs 359\u00a0pg\/mL, P\u00a0&amp;lt;\u00a0.001) and amyloid \u03b240 levels (median 9124 vs 6958\u00a0pg\/mL, P\u00a0=\u00a0.010) than CAA-ICH patients. ICH recurrence was higher in CAA-ICH (10.0 per 100 person-years), followed by MLH-ICH (6.0 per 100 person-years) and aSVD-ICH (1.3 per 100 person-years) (P\u00a0=\u00a0.048).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions<\/jats:title>\n                    <jats:p>Neuroimaging features, CSF neurodegeneration markers and ICH recurrence risk suggest that CAA is not the predominant pathology in most cases of MLH-ICH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/esj\/aakag052","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:43:37Z","timestamp":1779911017000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterisation of patients with intracerebral haemorrhage with mixed location haemorrhages: clinical and imaging features, CSF neurodegeneration markers and recurrence risk"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-7146","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Pinho","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-6616","authenticated-orcid":false,"given":"Ana Sofia","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]},{"name":"JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J\u00fclich GmbH and Medical Faculty, RWTH Aachen University , Wilhelm-Johnen-Stra\u00dfe, J\u00fclich 52428 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iason","family":"Bartzokis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"De Angelis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Weyland","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wiesmann","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9730-9228","authenticated-orcid":false,"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]},{"name":"JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J\u00fclich GmbH and Medical Faculty, RWTH Aachen University , Wilhelm-Johnen-Stra\u00dfe, J\u00fclich 52428 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]},{"name":"JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J\u00fclich GmbH and Medical Faculty, RWTH Aachen University , Wilhelm-Johnen-Stra\u00dfe, J\u00fclich 52428 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital RWTH Aachen , Pauwelsstr. 30, Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2026052715433368200_ref1","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI\u2013neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"key":"2026052715433368200_ref2","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1212\/WNL.0000000000004797","article-title":"Mixed-location cerebral hemorrhage\/microbleeds: underlying microangiopathy and recurrence risk","volume":"90","author":"Pasi","year":"2018","journal-title":"Neurology"},{"key":"2026052715433368200_ref3","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1212\/WNL.0000000000006953","article-title":"Microangiopathy underlying mixed-location intracerebral hemorrhages\/microbleeds: a PiB-PET study","volume":"92","author":"Tsai","year":"2019","journal-title":"Neurology"},{"key":"2026052715433368200_ref4","doi-asserted-by":"publisher","first-page":"e209719","DOI":"10.1212\/WNL.0000000000209719","article-title":"18FFlutemetamol-PET aided classification of cerebral amyloid angiopathy: a multicenter study","volume":"103","author":"Romoli","year":"2024","journal-title":"Neurology"},{"key":"2026052715433368200_ref5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","article-title":"The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds","volume":"73","author":"Gregoire","year":"2009","journal-title":"Neurology"},{"key":"2026052715433368200_ref6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1161\/STROKEAHA.119.024843","article-title":"Cerebellar microbleed distribution patterns and cerebral amyloid angiopathy: a MRI and pathology-based study","volume":"50","author":"Pasi","year":"2019","journal-title":"Stroke"},{"key":"2026052715433368200_ref7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging standards for research into small vessel disease\u2014advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026052715433368200_ref8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0735-1097(85)80115-7","article-title":"Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria","volume":"6","author":"Casale","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026052715433368200_ref9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"2026052715433368200_ref10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"Elm","year":"2007","journal-title":"Epidemiology"},{"key":"2026052715433368200_ref11","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000011378","article-title":"Long-term vascular outcomes in patients with mixed location intracerebral hemorrhage and microbleeds","volume":"96","author":"Tsai","year":"2021","journal-title":"Neurology"},{"key":"2026052715433368200_ref12","doi-asserted-by":"publisher","first-page":"e039474","DOI":"10.1161\/JAHA.124.039474","article-title":"Cardiac structure relates to hemorrhagic cerebral small vessel disease phenotype","volume":"15","author":"Stewart","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"2026052715433368200_ref13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fneur.2019.01126","article-title":"Underlying small vessel disease associated with mixed cerebral microbleeds","volume":"10","author":"Blanc","year":"2019","journal-title":"Front Neurol"},{"key":"2026052715433368200_ref14","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1161\/STROKEAHA.120.034096","article-title":"Deep cerebral perforators: anatomical distribution and clinical symptoms: an overview","volume":"52","author":"Vogels","year":"2021","journal-title":"Stroke"},{"key":"2026052715433368200_ref15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14737175.2022.2104157","article-title":"Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts","volume":"22","author":"Goeldlin","year":"2022","journal-title":"Expert Rev Neurother"},{"key":"2026052715433368200_ref16","doi-asserted-by":"publisher","first-page":"awaf413","DOI":"10.1093\/brain\/awaf413","article-title":"Estimating the time course of biomarker changes in Alzheimer\u2019s disease","author":"Raket","year":"2025","journal-title":"Brain"},{"key":"2026052715433368200_ref17","doi-asserted-by":"publisher","first-page":"e209795","DOI":"10.1212\/WNL.0000000000209795","article-title":"Core CSF biomarker profile in cerebral amyloid angiopathy: updated meta-analysis","volume":"103","author":"Charidimou","year":"2024","journal-title":"Neurology"},{"key":"2026052715433368200_ref18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.26610","article-title":"Decreased cerebrospinal fluid amyloid \u03b2 38, 40, 42 and 43 levels in sporadic and hereditary cerebral amyloid angiopathy","volume":"93","author":"De Kort","year":"2023","journal-title":"Ann Neurol"},{"key":"2026052715433368200_ref19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid \u03b240 is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann Neurol"},{"key":"2026052715433368200_ref20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","article-title":"Review: sporadic cerebral amyloid angiopathy","volume":"37","author":"Attems","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026052715433368200_ref21","doi-asserted-by":"publisher","first-page":"e70221","DOI":"10.1002\/dad2.70221","article-title":"Profiles of blood-brain barrier and neurodegeneration markers in cerebrospinal fluid of patients with cerebral amyloid angiopathy","volume":"17","author":"Pinho","year":"2025","journal-title":"Alzheimers Dement (Amst)"},{"key":"2026052715433368200_ref22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/17474930231152124","article-title":"Characterizing mixed location hemorrhages\/microbleeds with CSF markers","volume":"18","author":"Jensen-Kondering","year":"2023","journal-title":"Int J Stroke"},{"key":"2026052715433368200_ref23","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1212\/WNL.0000000000207476","article-title":"Mechanistic implications of cortical superficial siderosis in patients with mixed location intracerebral hemorrhages and cerebral microbleeds","volume":"101","author":"Das","year":"2023","journal-title":"Neurology"},{"key":"2026052715433368200_ref24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000513503","article-title":"Intracerebral hemorrhage recurrence in patients with and without cerebral amyloid angiopathy","volume":"11","author":"Pinho","year":"2021","journal-title":"Cerebrovasc Dis Extra"},{"key":"2026052715433368200_ref25","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1212\/WNL.0000000000207510","article-title":"Association of the presence and pattern of MRI markers of cerebral small vessel disease with recurrent intracerebral hemorrhage","volume":"101","author":"Fandler-H\u00f6fler","year":"2023","journal-title":"Neurology"},{"key":"2026052715433368200_ref26","doi-asserted-by":"publisher","first-page":"e2192","DOI":"10.1212\/WNL.0000000000008590","article-title":"Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: a meta-analysis","volume":"93","author":"Charidimou","year":"2019","journal-title":"Neurology"},{"key":"2026052715433368200_ref27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","article-title":"Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"2026052715433368200_ref28","doi-asserted-by":"publisher","first-page":"e042614","DOI":"10.1161\/JAHA.124.042614","article-title":"Cerebrospinal fluid A\u03b2 biomarkers predict recurrent hemorrhage and identify cerebral amyloid angiopathy in patients with lobar hemorrhage","volume":"14","author":"Arndt","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026052715433368200_ref29","doi-asserted-by":"publisher","first-page":"e044784","DOI":"10.1161\/JAHA.125.044784","article-title":"Cerebrospinal fluid biomarkers profiling in cerebral amyloid angiopathy and relationship with disease phenotypes","volume":"14","author":"Losa","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026052715433368200_ref30","doi-asserted-by":"publisher","first-page":"e0156992","DOI":"10.1371\/journal.pone.0156992","article-title":"The H-ATOMIC criteria for the etiological classification of patients with intracerebral hemorrhage","volume":"11","author":"Mart\u00ed-F\u00e0bregas","year":"2016","journal-title":"PLoS One"},{"key":"2026052715433368200_ref31","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/STROKEAHA.112.661603","article-title":"SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage","volume":"43","author":"Meretoja","year":"2012","journal-title":"Stroke"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/5\/aakag052\/68412851\/aakag052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/5\/aakag052\/68412851\/aakag052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:43:38Z","timestamp":1779911018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/doi\/10.1093\/esj\/aakag052\/8696329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/esj\/aakag052","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"aakag052"}}